The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Local M-CSF (Macrophage Colony-Stimulating Factor) Expression Regulates Macrophage Proliferation and Apoptosis in Atherosclerosis
Abstract
Objective: Previous studies have shown that deficiency of M-CSF (macrophage colony-stimulating factor; or CSF1 [colony stimulating factor 1]) dramatically reduces atherosclerosis in hyperlipidemic mice. We characterize the underlying mechanism and investigate the relevant sources of CSF1 in lesions. Approach and Results: We quantitatively assessed the effects of CSF1 deficiency on macrophage proliferation and apoptosis in atherosclerotic lesions. Staining of aortic lesions with markers of proliferation, Ki-67 and bromodeoxyuridine, revealed around 40% reduction in CSF1 heterozygous (Csf1 +/– ) as compared with WT (wild type; Csf1 +/+ ) mice. Similarly, staining with a marker of apoptosis, activated caspase-3, revealed a 3-fold increase in apoptotic cells in Csf1 +/– mice. Next, we determined the cellular sources of CSF1 contributing to lesion development. Cell-specific deletions of Csf1 in smooth muscle cells using SM22α-Cre (smooth muscle protein 22-alpha-Cre) reduced lesions by about 40%, and in endothelial cells, deletions with Cdh5-Cre (VE-cadherin-Cre) reduced lesions by about 30%. Macrophage-specific deletion with LysM-Cre (lysozyme M-Cre), on the other hand, did not significantly reduce lesions size. Transplantation of Csf1 null (Csf1 −/ − ) mice bone marrow into Csf1 +/+ mice reduced lesions by about 35%, suggesting that CSF1 from hematopoietic cells other than macrophages contributes to atherosclerosis. None of the cell-specific knockouts affected circulating CSF1 levels, and only the smooth muscle cell deletions had any effect on the percentage monocytes in the circulation. Also, Csf1 +/– mice did not exhibit significant differences in Ly6C high /Ly6C low monocytes as compared with Csf1 +/+ . Conclusions: CSF1 contributes to both macrophage proliferation and survival in lesions. Local CSF1 production by smooth muscle cell and endothelial cell rather than circulating CSF1 is the primary driver of macrophage expansion in atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There was also a modest decrease in atherosclerosis in controls, which is consistent with the known role of CSF1 signaling in promoting atherosclerosis in standard mouse atherosclerosis models46,65,66 (Fig. 4d).”
From Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis (2023) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Recent insights into the cellular biology of atherosclerosis
Tabas, I., García-Cardeña, G., & Owens, G. K. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201412052 · Cited by 1,016
CSF-1 regulation of the wandering macrophage: complexity in action
Pixley, F. J., & Stanley, E. R. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.09.016 · Cited by 807
Colony-stimulating factor-1 in immunity and inflammation
Chitu, V., & Stanley, E. R. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.006 · Cited by 635
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Gordts, P. L. S. M., Nock, R., Son, N.-H., Ramms, B., Lew, I., Gonzales, J. C., Thacker, B. E., Basu, D., Lee, R. G., Mullick, A. E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86610 · Cited by 274
Research works printed but not linked: 48
- 10.1073/pnas.87.12.4600 · DOI · Paper page
- 10.1126/science.1204351 · DOI
- 10.1016/S0002-9440(10)61163-7 · DOI
- 10.1084/jem.20090866 · DOI
- 10.1161/ATVBAHA.114.304649 · DOI
- 10.1182/blood-2008-07-170787 · DOI
- Watanabe, T, Hirata, M, Yoshikawa, Y, Nagafuchi, Y, Toyoshima, H, Watanabe, T. Role of macrophages in atherosclerosis. Sequential observations of cholesterol-induced rabbit aortic lesion by the immunoperoxidase technique using monoclonal antimacrophage antibody. Lab Invest. 1985;53:80–90.
- Ylitalo, R, Oksala, O, Ylä-Herttuala, S, Ylitalo, P. Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits. J Lab Clin Med. 1994;123:769–776.
- 10.1161/01.res.84.11.1237 · DOI
- 10.1161/01.atv.17.8.1517 · DOI
- 10.1161/CIRCULATIONAHA.110.956730 · DOI
- 10.1038/nm.1898 · DOI
- 10.1161/01.atv.18.4.631 · DOI
- Qiao, JH, Tripathi, J, Mishra, NK, Cai, Y, Tripathi, S, Wang, XP, Imes, S, Fishbein, MC, Clinton, SK, Libby, P, et al. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am J Pathol. 1997;150:1687–1699.
- 10.1172/JCI119891 · DOI
- 10.1038/344254a0 · DOI
- 10.1073/pnas.92.18.8264 · DOI
- 10.1038/nm.3258 · DOI · Paper page
- Clinton, SK, Underwood, R, Hayes, L, Sherman, ML, Kufe, DW, Libby, P. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol. 1992;140:301–316.
- 10.1128/MCB.00103-18 · DOI
- 10.1189/jlb.0310158 · DOI
- 10.1182/blood.v98.1.74 · DOI
- 10.1194/jlr.M005215 · DOI
- 10.1161/01.cir.91.9.2488 · DOI
- 10.1161/ATVBAHA.118.311266 · DOI
- 10.1161/ATVBAHA.114.303617 · DOI
- 10.1084/jem.177.1.237 · DOI
- 10.1016/j.stem.2018.07.011 · DOI
- 10.1189/jlb.1209822 · DOI · Paper page
- Rosenfeld, ME, Ylä-Herttuala, S, Lipton, BA, Ord, VA, Witztum, JL, Steinberg, D. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol. 1992;140:291–300.
- 10.1038/s41586-019-0948-2 · DOI · Paper page
- 10.1038/ni.1744 · DOI · Paper page
- 10.4049/jimmunol.176.11.6594 · DOI
- 10.1074/jbc.M112.355610 · DOI
- 10.1038/ncomms2877 · DOI
- 10.1002/j.1460-2075.1992.tb05181.x · DOI
- 10.1242/jcs.075309 · DOI
- 10.1182/blood-2016-05-714329 · DOI
- 10.1084/jem.180.2.705 · DOI
- 10.1016/S0021-9258(17)45392-0 · DOI
- 10.1186/gb-2009-10-11-r130 · DOI
- 10.1016/j.jim.2014.05.009 · DOI
- 10.3389/fimmu.2019.03046 · DOI
- 10.1016/s0165-0378(01)00111-5 · DOI
- 10.1172/JCI11380 · DOI
- 10.1161/CIRCULATIONAHA.107.745091 · DOI
- 10.1172/JCI29950 · DOI · Paper page
- 10.4049/jimmunol.177.6.4055 · DOI
Cited by
Efferocytosis induces macrophage proliferation to help resolve tissue injury
Gerlach, B. D., Ampomah, P. B., Yurdagul, A., Liu, C., Lauring, M. C., Wang, X., Kasikara, C., Kong, N., Shi, J., Tao, W., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.10.015 · Cited by 360
Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis
Liu, W., Yalcinkaya, M., Maestre, I. F., Olszewska, M., Ampomah, P. B., Heimlich, J. B., Wang, R., Vela, P. S., Xiao, T., Bick, A. G., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00281-3 · Cited by 93
Cardiac Macrophages across Space and Time: Roles in Homeostasis, Disease, and Remodeling
Shrestha, S., & Dick, S. A. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.02.025 · Cited by 7
Metadata
- Authors
- Sinha, S. K., Miikeda, A., Fouladian, Z., Mehrabian, M., Edillor, C., Shih, D., Zhou, Z., Paul, M. K., Charugundla, S., Davis, R. C., Rajavashisth, T. B., & Lusis, A. J.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2021-01
- Volume
- 41
- Issue
- 1
- Pages
- 220-233
- ISSN
- 1079-5642
- 1524-4636
- PMC
- PMC7769919
- Cited by
- 88
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review